Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ret Proto-Oncogene anticorps (AA 702-848)

Cet anticorps Souris Monoclonal détecte spécifiquement Ret Proto-Oncogene dans ELISA et Coat. Il présente une réactivité envers Humain.
N° du produit ABIN6938321

Aperçu rapide pour Ret Proto-Oncogene anticorps (AA 702-848) (ABIN6938321)

Antigène

Voir toutes Ret Proto-Oncogene (RET) Anticorps
Ret Proto-Oncogene (RET)

Reactivité

  • 169
  • 93
  • 69
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 175
  • 43
  • 2
  • 2
  • 1
  • 1
Souris

Clonalité

  • 173
  • 51
Monoclonal

Conjugué

  • 91
  • 15
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp Ret Proto-Oncogene est non-conjugé

Application

  • 169
  • 81
  • 65
  • 65
  • 54
  • 25
  • 18
  • 17
  • 14
  • 12
  • 10
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, Coating (Coat)

Clone

RET-2976
  • Épitope

    • 23
    • 19
    • 18
    • 15
    • 15
    • 15
    • 11
    • 9
    • 9
    • 8
    • 8
    • 8
    • 7
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 702-848

    Specificité

    The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney.Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: ELISA (For coating, order Ab without BSA)Optimal dilution for a specific application should be determined.

    Positive_Control: Breast, Prostate or Colon Carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    Ret Proto-Oncogene (RET)

    Autre désignation

    RET

    Sujet

    Cadherin family member 12 (CDHF12), Cadherin related family member 16 (CDHR16), ELKS, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, RET51, RET9,RET Proto-oncogene
    Cellular localisation: Cytoplasmic, Cell Surface and Nuclear

    Poids moléculaire

    150kDa (precursor), 170kDa (Mature)

    ID gène

    5979, 350321

    UniProt

    P07949

    Pathways

    Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Vous êtes ici:
Chat with us!